Nephros (NEPH) Earnings Analysis

Nephros (NEPH) next reports earnings on 2026-08-06, consensus EPS 0.01 USD. Last quarter (2026-05-07) it beat with EPS 0.01 USD vs 0.01 USD est (0%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 49.93.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NEPH next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.01 USD
Revenue estimate0.00B

NEPH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.01 USD0.01 USD0%Beat
2026-03-120.01 USD0.01 USD0%Beat
2025-11-060.03 USD-0.02 USD+250%Beat
2025-05-090.05 USD-0.005 USD+1100%Beat
2025-03-070.03 USD-0.01 USD+400%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

NEPH valuation and analyst view

Trailing P/E49.93
Trailing EPS0.07286 USD
Price / book3.63
Dividend yield0.00%
Market cap0.04B
Analyst consensusBuy (4 buy / 0 hold / 0 sell)
Avg price target4 USD

Related research pages

Frequently asked questions

When is Nephros (NEPH)'s next earnings date?

Nephros is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.01 USD and revenue estimate of 0.00B.

Did NEPH beat earnings last quarter?

In its 2026-05-07 report, NEPH posted EPS of 0.01 USD versus a 0.01 USD estimate — a beat of 0%.

What is NEPH's earnings track record?

Over the last 5 reported quarters with consensus data, NEPH beat estimates 5 times (100%).

What is NEPH's current P/E ratio and EPS?

NEPH trades at a trailing P/E of 49.93 on trailing EPS of 0.07285824686345717 USD.

What do analysts rate NEPH?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 4 USD.